118 related articles for article (PubMed ID: 6980189)
1. Identification by monoclonal antibodies of T-cell subpopulations activated by 12-O-tetradecanoylphorbol-13-acetate (TPA).
Kaplan JH; Lee LS; Lockwood SH
Immunol Lett; 1982 May; 4(5):269-73. PubMed ID: 6980189
[TBL] [Abstract][Full Text] [Related]
2. TPA, tumor promoter-induced suppression of immunoglobulin secretion in human blood lymphocytes.
Jagielski P; Gregg SL; Gajl-Peczalska KJ
J Immunol; 1983 Mar; 130(3):1159-63. PubMed ID: 6600475
[TBL] [Abstract][Full Text] [Related]
3. Proliferative response of normal and activated human lymphocytes to tetradecanoyl phorbol acetate.
Ashman LK
Cell Immunol; 1984 Sep; 87(2):613-25. PubMed ID: 6331899
[TBL] [Abstract][Full Text] [Related]
4. Changes in SRBC binding capacity and T-surface antigen expression on human peripheral blood lymphocytes stimulated by 12-O-tetradecanoylphorbol-13-acetate (TPA).
Matera L; Foa R; Marmont F; Massaia M; Palumbo A; Pegoraro L
J Clin Lab Immunol; 1983 Sep; 12(1):57-61. PubMed ID: 6688831
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the response of human thymocytes and blood lymphocytes to the synergistic mitogenicity of 12-O-tetradecanoylphorbol-13-acetate (TPA)-ionomycin.
Delia D; Greaves M; Villa S; DeBraud F
Eur J Immunol; 1984 Aug; 14(8):720-4. PubMed ID: 6332025
[TBL] [Abstract][Full Text] [Related]
6. Induction of human T colony formation by phorbol myristate acetate.
Klein B; Rey A; Jourdan M; Donnadieu MH; Serrou B
Scand J Immunol; 1983 Apr; 17(4):329-34. PubMed ID: 6601295
[TBL] [Abstract][Full Text] [Related]
7. Sézary cells with an unusual phenotype, their modulation with 12-O-tetradecanoyl phorbol-13-acetate (TPA) in vitro, and their relationship to T-cell development.
Kvaløy S; Lindmo T; Davies C; Wisløff F; Godal T
J Clin Immunol; 1983 Jul; 3(3):212-21. PubMed ID: 6604064
[TBL] [Abstract][Full Text] [Related]
8. Analysis of T cell activation with a non-mitogenic anti CD3 antibody and the phorbol ester TPA.
Holter W; Majdic O; Stockinger H; Knapp W
Clin Exp Immunol; 1985 Dec; 62(3):600-6. PubMed ID: 3002691
[TBL] [Abstract][Full Text] [Related]
9. Activation of T lymphocytes by 12-O-tetradecanoylphorbol-13-acetate is resistant to inhibition by cyclosporin A.
Kay JE; Meehan RT; Benzie CR
Immunol Lett; 1983; 7(3):151-6. PubMed ID: 6607880
[TBL] [Abstract][Full Text] [Related]
10. Comparison of phorbol myristate acetate and phytohaemagglutinin as stimulators of in vitro T lymphocyte colony formation of human peripheral blood lymphocytes. I. Surface markers of colony cells.
Suzawa T; Hyodo S; Kishi T; Kashiwa H; Karakawa T; Kittaka E; Sakano T; Usui T
Immunology; 1984 Nov; 53(3):499-505. PubMed ID: 6333386
[TBL] [Abstract][Full Text] [Related]
11. Induction of differentiation in human T-lymphoblastic leukemia cell lines by 12-O-tetradecanoylphorbol 13-acetate (TPA): studies with monoclonal antibodies to T cells.
Nagasawa K; Mak TW
Cell Immunol; 1982 Aug; 71(2):396-403. PubMed ID: 6982771
[No Abstract] [Full Text] [Related]
12. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
Kunicka JE; Platsoucas CD
Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
[TBL] [Abstract][Full Text] [Related]
13. Phorbol ester tumor promoter modulation of alloantigen-specific T lymphocyte responses.
Andreotti PE
J Immunol; 1982 Jul; 129(1):91-6. PubMed ID: 6177764
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of enhancement of Epstein-Barr virus-induced transformation of peripheral blood lymphocytes by a tumor promoter, TPA, with special reference to lowering of cytotoxicity of T cells.
Harada S; Katsuki T; Yamamoto H; Hinuma Y
Int J Cancer; 1981 May; 27(5):617-23. PubMed ID: 6270019
[TBL] [Abstract][Full Text] [Related]
15. The tumour promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) induces the production of lymphocyte-activating factors (LAP) in human lymphocyte cultures.
Abb J; Deinhardt F
Arch Geschwulstforsch; 1980; 50(4):327-31. PubMed ID: 6970023
[TBL] [Abstract][Full Text] [Related]
16. 12-O-Tetradecanoylphorbol-13-acetate (TPA) directly inhibits spontaneous immunoglobulin secretion by in vivo antigen-induced human lymphoblastoid B cells.
Brieva JA; Louie JS; Stevens RH
J Clin Immunol; 1984 Jul; 4(4):280-6. PubMed ID: 6611348
[TBL] [Abstract][Full Text] [Related]
17. Serological analysis of cell surface antigens of HL-60 cells before and after treatment with a phorbol ester tumor promoter.
Namikawa R; Ogata S; Ueda R; Tsuge I; Nishida K; Minami S; Koike K; Suchi T; Ota K; Iijima S; Takahashi T
Leuk Res; 1983; 7(3):375-87. PubMed ID: 6604202
[TBL] [Abstract][Full Text] [Related]
18. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD2 (sheep red blood cell receptor) monoclonal antibodies and T cell activation. I. Pairs of anti-T11.1 and T11.2 (CD2 subgroups) are strongly mitogenic for T cells in presence of 12-O-tetradecanoylphorbol 13-acetate.
Olive D; Ragueneau M; Cerdan C; Dubreuil P; Lopez M; Mawas C
Eur J Immunol; 1986 Sep; 16(9):1063-8. PubMed ID: 2428622
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte activation by the tumor-promoting agent 12-O-tetradecanoylphorbol-13-acetate (TPA).
Abb J; Bayliss GJ; Deinhardt F
J Immunol; 1979 May; 122(5):1639-42. PubMed ID: 221578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
